Thomas Vallim

Non-alcoholic fatty liver disease: A sign of systemic disease

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Fatty acid transport proteins, implications in physiology and disease

The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease

Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors

Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

Real-Time Noninvasive Imaging of Fatty Acid Uptake in Vivo

Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology

Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

Mechanisms and regulation of cholesterol homeostasis

Mechanisms of Insulin Action and Insulin Resistance

Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance

Nonalcoholic Fatty Liver Disease

SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression

Regulation of hepatic gene expression by saturated fatty acids